Clinical Overview
Clinical Overview
Clinical Overview For Providers
A Physiological, Brain-Focused Approach to Concussion Care After Auto Accidents
Rocky Mountain Concussion was built on a simple but often overlooked reality:
a concussion is a physiological and metabolic brain injury, not merely a collection of symptoms.
While symptoms may fluctuate or resolve over time, the underlying neurological disruption caused by acceleration–deceleration forces can persist well beyond the acute phase. Effective concussion care requires addressing what is happening at the cellular, metabolic, and systems level within the brain.
This Clinical Overview outlines the scientific principles that guide our approach to concussion care after motor vehicle accidents.
The Neurophysiology of Concussion
Whiplash and concussion commonly occur together after motor vehicle collisions. Cervical joint dysfunction, soft tissue injury, and altered biomechanics often coexist with functional brain injury caused by rapid acceleration and deceleration forces.
Because neck pain and headaches are frequently the most obvious complaints, underlying neurological dysfunction can be masked early in care. As a result, patients may improve structurally while continuing to struggle with symptoms such as dizziness, brain fog, visual strain, fatigue, or poor tolerance to rehabilitation.
When concussion-related dysfunction goes unaddressed, recovery can plateau despite appropriate musculoskeletal treatment.
Why Rest Alone Is Often Insufficient
Early cognitive and physical rest plays an important role immediately after injury. However, rest alone does not directly address:
Impaired mitochondrial energy production
Ongoing neuroinflammation
Disrupted autonomic regulation
Altered sensory integration (vestibular and visual systems)
Without targeted intervention, patients may experience persistent symptoms, delayed recovery, or incomplete neurological healing — even if they appear “clinically improved.”
True recovery requires active, guided support of the brain’s healing environment.
Metabolic Support and Neurological Healing
Rocky Mountain Concussion’s care model is built around optimizing the conditions necessary for neurological recovery.
This includes:
Restoring cellular energy availability
Reducing inflammatory burden
Supporting neuroplastic repair mechanisms
Improving tolerance to cognitive and physical exertion
By addressing these factors, patients are better equipped to engage in rehabilitation and progress through recovery safely and efficiently.
Peptide-Based Neurotherapeutics
Concussion is not simply a temporary disruption — it is a biological brain injury involving inflammation, impaired energy metabolism, disrupted signaling, and reduced neuroplasticity. In addition to rehabilitation and monitoring, Rocky Mountain Concussion incorporates targeted peptide-based and neuro-supportive therapies to help optimize the brain’s healing environment.
Peptide Therapies Used At Rocky Mountain Concussion
RMC utilizes a select group of peptides supported by emerging neurological and regenerative research:
Cerebrolysin
A neuropeptide compound with neurotrophic properties that supports neuronal repair, synaptic plasticity, and recovery after traumatic brain injury. Cerebrolysin has been studied for its role in improving cognitive function and neurological outcomes following brain injury.
Thymosin Beta-4 (TB-4)
A regenerative peptide involved in cellular repair, angiogenesis, and inflammation modulation. In concussion care, TB-4 is used to support tissue recovery and optimize the brain’s healing environment after trauma.
BPC-157
A body-protective peptide shown to support vascular integrity, tissue healing, and neuroinflammatory modulation. BPC-157 is incorporated to assist recovery from both neurological and associated cervical or soft-tissue injury commonly seen after auto accidents.
Intranasal Neuro-Modulating Peptides
RMC also utilizes intranasal peptide therapies, allowing direct access to the central nervous system through the olfactory pathway:
Semax
A neuroactive peptide studied for cognitive support, neuroprotection, and regulation of stress-related neurochemical pathways. Semax may support focus, memory, and cerebral blood flow during recovery.
Selank
A peptide with anxiolytic and neuroregulatory effects, used to help support emotional regulation, cognitive clarity, and autonomic balance during concussion recovery.
RG3
Utilized as part of RMC’s neuro-supportive protocols to assist with neurological signaling and recovery optimization.
Healing & Neuro-Supportive Supplements
To further support brain recovery at the cellular level, RMC incorporates targeted supplements alongside peptide therapy:
NAD (Nicotinamide Adenine Dinucleotide) — supports mitochondrial function and cellular energy production
NeuroMag — magnesium formulation designed to support neurological signaling and excitability regulation
Creatine — supports cellular energy buffering and neuroprotection
Additional supportive nutrients selected based on individual clinical presentation.
Integrated, Monitored & Individualized Care
All peptide therapies and supplements are:
Medically evaluated and prescribed
Integrated with physical and neurological rehabilitation
Monitored over time to assess response and progress
Adjusted based on each patient’s recovery trajectory
These therapies are not used in isolation, but as part of a comprehensive concussion care model designed to address both biological injury and functional recovery.
Systems-Level Rehabilitation
Neurological recovery after concussion requires more than metabolic support alone. Functional systems disrupted by concussion must also be retrained and reintegrated.
Rocky Mountain Concussion evaluates and supports recovery across multiple systems, including:
Vestibular System
Disruption of balance and spatial orientation can lead to dizziness, vertigo, and motion sensitivity.
Visual and Oculomotor Function
Impaired eye tracking, convergence, and visual processing can contribute to headaches, fatigue, and difficulty reading or focusing.
Cervical–Neurological Integration
Neck injury and altered proprioception frequently interact with concussion symptoms, particularly after whiplash mechanisms.
Autonomic Nervous System Regulation
Exercise intolerance, heart rate dysregulation, and fatigue are often signs of autonomic imbalance following concussion.
Rehabilitation is guided, progressive, and individualized — designed to restore coordination between the brain and body as healing occurs.
Objective Monitoring and Recovery Progression
Symptom resolution alone does not reliably indicate neurological recovery.
Rocky Mountain Concussion emphasizes:
ongoing assessment of functional recovery
monitoring of tolerance to cognitive and physical activity
adjustment of care based on objective findings and patient response
This approach allows recovery to be tracked rather than assumed, helping reduce the risk of premature discharge or lingering impairment.
Integration Within the Post-Accident Care Continuum
Rocky Mountain Concussion does not replace existing providers. We integrate within a broader care network that may include:
Attorneys
Chiropractors
Urgent Care and Emergency Providers
Physical Therapists
Medical Groups & Primary Care Doctors
Our role is to address the neurological component of injury that is frequently underrecognized, while supporting coordinated, patient-centered recovery.
Why This Approach Matters
When concussion is treated only at the symptom level, patients may heal incompletely and remain vulnerable to persistent dysfunction.
By addressing concussion as a physiological brain injury — and supporting recovery at the cellular, metabolic, and functional levels — Rocky Mountain Concussion offers a more complete and scientifically grounded path to healing.
For Providers and Attorneys
For questions regarding clinical protocols, referral pathways, or collaborative care, we invite you to contact our team or explore the provider-specific resources available throughout this site.
Selected Research & Evidence Base
Rocky Mountain Concussion’s clinical approach is grounded in a growing body of neuroscience and concussion research demonstrating that concussion is a metabolic and physiological brain injury, not simply a transient symptom condition.
Neurometabolic Cascade & Energy Crisis
Research has shown that concussion disrupts cellular energy production, cerebral blood flow, and mitochondrial function, creating a prolonged neurometabolic vulnerability:
Giza CC, Hovda DA. The neurometabolic cascade of concussion.
Journal of Athletic Training, 2001.Foundational paper describing ionic flux, excitotoxicity, impaired glucose metabolism, and mitochondrial dysfunction following concussion.
Giza CC, Hovda DA. The pathophysiology of traumatic brain injury.
Neurosurgery, 2014.Expanded understanding of prolonged metabolic disruption and impaired cerebral energy balance after mild TBI.
Cerebral Blood Flow & Autonomic Dysfunction
Multiple studies demonstrate persistent reductions in cerebral blood flow and autonomic dysregulation after concussion, even when symptoms appear to improve:
Len TK et al. Alterations in cerebral blood flow after sports concussion.
Journal of Cerebral Blood Flow & Metabolism, 2011.La Fountaine MF et al. Autonomic nervous system dysfunction following mild traumatic brain injury.
Brain Injury, 2011.
Symptom Resolution ≠ Neurological Recovery
Evidence shows that neurological recovery often lags behind symptom resolution, underscoring the risk of premature discharge based on symptoms alone:
McCrea M et al. Acute effects and recovery time following concussion in collegiate athletes.
JAMA, 2003.Slobounov S et al. Residual brain dysfunction observed one year post-mild traumatic brain injury.
NeuroImage, 2010.
Active Rehabilitation & Targeted Recovery
Modern concussion research supports guided, progressive rehabilitation rather than prolonged rest alone:
Leddy JJ et al. Rehabilitation of concussion and post-concussion syndrome.
Sports Health, 2012.Schneider KJ et al. Cervicovestibular rehabilitation in sport-related concussion.
British Journal of Sports Medicine, 2014.
Peptides, Neuroinflammation & Neural Repair (Emerging Evidence)
While still an evolving field, peer-reviewed research supports the role of specific peptides and peptide analogs in neurological repair, inflammation modulation, and neuroprotection:
Thon N et al. Cerebrolysin in patients with traumatic brain injury.
CNS Drugs, 2012.Demonstrated neurotrophic and neuroprotective effects supporting functional recovery.
Dash PK et al. Neuroprotective peptides and traumatic brain injury.
Peptides, 2009.Zaninotto AL et al. Neuroplasticity and recovery after traumatic brain injury.
NeuroRehabilitation, 2010.
These findings support the rationale for biologically targeted therapies that address inflammation, cellular energy, and neuroplasticity as part of a comprehensive concussion recovery strategy.
Important Note on Clinical Application
Peptide-based therapies are incorporated as evidence-informed, medically guided tools and are integrated with rehabilitation, monitoring, and individualized care. Ongoing research continues to refine best practices in this rapidly advancing area of neurotherapeutics.